T hymic stromal lymphopoietin (TSLP) was originally identified as a growth-promoting factor produced by mouse thymic stromal cells that supported the development of immature B cells to the B220 + /IgM + stage (1) . TSLP is a type I cytokine that acts via a receptor containing IL-7Ra and a TSLPspecific subunit, TSLP receptor (TSLPR) (2, 3) ; it signals via JAK1 and JAK2 to mediate the activation of STAT5A and STAT5B (4) . TSLPR is most similar to the common cytokine receptor g-chain, g c , which is a component of the receptors for IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21 (5) and whose mutation results in X-linked SCID in humans (6) .
TSLP has been implicated in the development of asthma (7), atopic dermatitis (8) , and inflammatory arthritis (9) . Moreover, it is required for normal worm expulsion during helminth infection (10) and for the inflammatory process that promotes cancer progression and metastasis (11) (12) (13) . In addition to its actions on B cells, TSLP acts on other lineages, including dendritic cells (DCs) (14) , T cells (4, 15, 16) , mast cells (17) , NKT cells (18) , and eosinophils (19) . TSLP can act via DCs to regulate the activation, differentiation, and homeostasis of T cells (8) , but it also has direct effects on T cells, promoting their survival and proliferation in response to TCR activation (15, 16, 20) . Interestingly, TSLPR knockout (KO) mice have a defective allergic inflammatory response in the lung, but this can be reversed by adoptive transfer of wild-type (WT) CD4 + T cells (7), underscoring a key role for the action of TSLP on these cells.
TSLP is expressed by a range of cell types, including epithelial cells, fibroblasts, keratinocytes, IgER-activated mast cells, protease-activated basophils, and human CD68 + macrophages, whereas it is not produced by other lympho-hematopoietic cells, including neutrophils, B cells, T cells, monocytes, myeloid DCs (mDCs), plasmacytoid DCs (pDCs), and endothelial cells (14, (21) (22) (23) . Because DCs are involved in the initiation of immune responses, we decided to re-explore the possibility that DCs might also produce TSLP. Activation of DCs via TLRs is known to induce the expression of MHC class II, CD80, and CD86 and to induce the secretion of inflammatory cytokines and chemokines that are important for the adaptive immune response (24) (25) (26) (27) . We now show that TLR signals also induce the production of TSLP by bone marrow-derived DCs and that this is augmented by IL-4, with mDCs producing much higher levels of TSLP compared with pDCs. TSLP expression was also induced by murine splenic DCs, human monocytes, and monocyte-derived DCs (MDDCs). Moreover, when lung cells were sorted into epithelial cells or DCs, TSLP mRNA was expressed by the epithelial cells and by the DCs, and levels were enhanced when mice were challenged with house dust mite (HDM) extract, which induces allergic inflammation in the lung (28) . Therefore, our study revealed that, in addition to their response to TSLP, DCs can produce TSLP in response to pathogens/allergens, with increased production in the presence of IL-4. The production of TSLP by DCs might bypass the need for epithelial cell-derived TSLP, potentially creating an autocrine loop wherein DCs both produce and respond to TSLP, as well as serving as a source of TSLP for other immune cells.
sorted into CD11c + B220 + cells using a MoFlo cell sorter (Beckman Coulter). Cells were activated with polyinosinic-polycytidylic acid (poly-I:C) (10 mg/ml), single-stranded polyuridine (1 mg/ml), and flagellin (1 mg/ ml) (Invivogen) or for varying periods of time with 10 mg/ml zymosan (Invivogen), 1 mg/ml LPS (Sigma), or 0.1 mM CpG (Alexis Biochemicals), with or without 10 ng/ml IL-4 (PeproTech), and TSLP mRNA and protein expression was evaluated. Splenic DCs were isolated using mouse pan-DC beads (Miltenyi Biotec). These cells were 80-85% pure based on staining with CD11c and B220 (BD Biosciences) and were activated with LPS or CpG for varying time points. Human monocytes were isolated using CD14 beads (Miltenyi Biotec) and cultured with human GM-CSF (50 ng/ml) and IL-4 (10 ng/ml) (PeproTech) for 7 d. The cells were washed and then stimulated with LPS and zymosan for 4 or 16 h to evaluate TSLP mRNA and protein expression, respectively. Monocyte and MDDC purity was assessed by staining with PE-Cy7-CD14 (BD Pharmingen) and FITCCD1c (Miltenyi Biotec). Monocyte purity was 85-90%, and MDDC purity was 85-90% after 7 d of culture in GM-CSF plus IL-4. Staining with FITC-Annexin V (BD Pharmingen) and 7-aminoactinomycin D (Molecular Probes) was used to distinguish living and dead cells. Bronchoalveolar lavage (BAL) fluid cells were stained with FITC-conjugated Ly-6G, PECD11c, and allophycocyanin-CD11b (BD Pharmingen and eBioscience) to distinguish neutrophils from DCs. PE-TCRb (BD Pharmingen) was used to identify T cells.
RNA isolation and real-time PCR
RNA was extracted using TRIzol reagent (Invitrogen) or RNeasy kit (Qiagen), reverse-transcribed using the Omniscript cDNA synthesis kit (Qiagen), and cytokine cDNAs were identified by a fluorogenic 59-nuclease PCR assay and an ABI Prism 7900HT sequence detection system (Perkin Elmer). One microgram of RNA was used for RT-PCR, and 0.2 mg this product was amplified using mouse or human TSLP, TNF-a, thymus and activation-regulated chemokine (TARC), MIP-1a, pulmonary surfactantassociated protein B (SFTPB), and IL-8 TaqMan FAM-MGB primers (Applied Biosystems), and mRNA levels were measured using standard curves relative to mouse or human RPL7 mRNA. The primers used for mouse Rpl7 were 59-TACCCAAGCGACTGGTCAGA-39 and 59-TGGGA-GGCGTTGGTGTCT-39, and the TaqMan FAM-TAMRA probe was 59-TGACATGCTGGCAGAGAGGCGAGATT-39; the primers for human RPL7 were 59-ACGCTTTGATTGCTCGATCTC-39 and 59-CCTCTTTGAAGCG-TTTTCCAA-39, and the TaqMan FAM-TAMRA probe was 59-ATACGG-CATCATCTGCATGGAGGATTTGAT-39.
HDM-induced lung inflammation and isolation of lung epithelial cells and DCs
BALB/c mice were injected intratracheally with PBS or HDM (Greer Laboratories) on days 0, 7, and 14 and sacrificed on day 17, and BAL fluid was collected. Two milliliters of dispase (Qiagen) was injected intratracheally. The lungs were subsequently incubated in 1 ml dispase for 45 min at room temperature, after which they were minced into small pieces in 5 ml RPMI 1640 medium supplemented with HEPES and 1 mg/ml DNase I (Sigma) and shaken for 10 min; subsequently, cell-single suspensions were prepared by passage through mesh. After lysis of RBCs with ACK buffer, the remaining cells were stained with PE-anti-CD11c (BD Pharmingen) and Alexa Fluor 647 anti-CD324 (Decma-1; eBioscience) and sorted using a MoFlo cell sorter (Beckman Coulter). The purity of the cells was 85-95%. A small part of the lung was homogenized in 1 ml PBS containing protease inhibitor mixture tablet (Roche Diagnostics), and the supernatant was used for measuring TSLP and TARC.
ELISA
A total of 1 or 2 3 10 6 mouse DCs was cultured with medium alone or medium containing LPS, CpG, or zymosan with or without IL-4 for 16 h. BAL fluid, lung supernatant, and in vitro culture supernatants were collected, and the concentration of TSLP, TARC, and MIP-1a was determined using an ELISA kit (R&D Systems and Antigenix).
Western blot
A total of 6-10 3 10 6 freshly isolated monocytes or 7-d-old MDDCs was stimulated with LPS or zymosan for 12 h plus 4 h with Golgi plug (Sigma) (total stimulation time = 16 h). The cells were then lysed and subjected to Western blot analysis with sheep anti-human TSLP primary Ab for TSLP 
detection (R&D Systems
). As a loading control, the membrane was stripped to check for expression of b-actin (Sigma).
Statistics
Results are expressed as mean 6 SD. The p values , 0.05, as determined by the Student t test using Prism 4 software, were considered significant.
Results
Mouse bone marrow-derived and splenic DCs express TSLP, and this expression is augmented by IL-4
To determine whether DCs can produce TSLP, we first analyzed GM-CSF-induced mouse bone marrow-derived DCs. Treatment of these cells with the TLR ligands zymosan, LPS, and CpG, which signal via TLR2/6, TLR4, and TLR9, respectively, each significantly induced TSLP mRNA (Fig. 1A) ; as expected, these stimuli also significantly induced TNF-a mRNA (Fig. 1B) , analogous to a previous report (27) . Poly-I:C, flagellin, and singlestranded polyuridine, which signal via TLR3, TLR5, and TLR7, respectively, had weaker effects on both TSLP (Fig. 1A) and TNFa (Fig. 1B) induction, with only flagellin significantly inducing TSLP mRNA, albeit more modestly than zymosan, LPS, and CpG (Fig. 1A) . Zymosan (Fig. 1C) , LPS (Fig. 1D) , and CpG (Fig. 1E ) each induced TSLP mRNA within 4 h, but these agents differ in their kinetics, with peak TSLP mRNA expression occurring earliest in response to zymosan. In addition to the production of TSLP mRNA by bone marrow-derived DCs, TSLP mRNA was produced by splenic DCs (Fig. 1F) . Because IL-4 was reported to augment TSLP production by keratinocytes, fibroblasts, and epithelial cells when combined with TNF-a, IL-1b, or poly-I:C (29, 30), we evaluated the effect of IL-4 on TSLP expression. IL-4 augmented zymosan-, LPS-, and CpG-induced TSLP mRNA expression (Fig. 1G ) and protein secretion (Fig. 1H ) from bone marrow-derived DCs. Consistent with a key role for STAT6 in IL-4 signaling, IL-4 did not induce TSLP mRNA (Fig. 1G) 
TSLP production by mDCs but not by pDCs
To further explore the range of DCs that can produce TSLP, we cultured bone marrow cells with either GM-CSF for 8-12 d to produce mDCs (31) or with FLT-3L to generate pDCs (32) . In response to LPS or CpG, TSLP mRNA expression was potently induced in mDCs, but little, if any, TSLP was induced in pDCs ( Fig. 2A) . In contrast, expression of MIP-1a, a chemokine known to be produced by both mDCs and pDCs (33) , was increased in both populations of DCs (Fig. 2B) . Correspondingly, LPS and CpG induced TSLP protein secretion by mDCs but not pDCs (Fig.  2C) , whereas MIP-1a protein was secreted by both cell types (Fig.  2D) . The detection of TSLP protein in the supernatant reflected secretion rather than release from dying cells, because LPS and CpG did not diminish the viability of the different DC populations (Fig. 2E) . Thus, mDCs, but not pDCs, are producers of TSLP.
Human peripheral blood monocytes and MDDCs also express TSLP
Monocytes from human blood develop into DCs when cultured with GM-CSF plus IL-4, and these MDDCs can function as potent APCs (34, 35) . Therefore, we used freshly isolated human monocytes (Fig. 3A) and MDDCs (Fig. 3B) and found that TSLP mRNA was induced in both populations by either LPS or zymosan (Fig. 3C) . As expected, as a control, IL-8 mRNA expression was also induced in both populations, but the basal and LPS-and zymosan-induced levels in MDDCs were lower than in monocytes (Fig. 3D) . Western blot analysis of monocytes and MDDCs revealed upregulation of TSLP protein upon LPS and zymosan stimulation (Fig. 3E) . Hence, human monocytes and MDDCs also express TSLP.
Lung epithelial cells and DCs produce TSLP in response to HDM challenge in vivo
Above, we examined the ability of different DC populations to produce TSLP after being challenged in vitro. We next used intratracheally administered HDM extract as an in vivo stimulus (Materials and Methods). As expected, HDM induced an inflammatory response, with increased cells in the BAL fluid (Fig.  4A) , with a higher percentage of neutrophils (Fig. 4B ) and T cells (Fig. 4C) , but a lower percentage of DCs (Fig. 4D) , in the BAL fluid of HDM-challenged mice. Both TARC (Fig. 4E) , a chemokine responsible for recruiting Th2 cells (36) , and TSLP (Fig. 4F) were significantly higher in the lung after HDM challenge. To assess the source of production of TARC and TSLP, we isolated epithelial cells and DCs by cell sorting. Interestingly, basal levels of TSLP (Fig. 4G) and TARC (Fig. 4H) 4H ) in both populations of cells. As expected, mRNA encoding pulmonary SFTPB was only expressed by the epithelial cells (Fig. 4I) , confirming that the effects that we observed did not result from contamination of DCs by epithelial cells. These results established that HDM-mediated lung inflammation is associated with the production of TSLP by lung DCs, as well as by primary epithelial cells.
Discussion
In this study, we demonstrated that multiple activators of TLRs, including zymosan, LPS, and CpG, could each induce expression of TSLP in mouse bone marrow-derived DCs and splenic DCs. Interestingly, TLR-induced TSLP production by bone marrowderived DCs was augmented by IL-4; as anticipated, this was via a STAT6-dependent mechanism. Increased TSLP expression was also observed in both freshly isolated human monocytes and MDDCs. The production of TSLP by DCs suggests possible autocrine effects on DCs; moreover, DCs may serve as a source of TSLP for other responsive lineages, such as CD4 + T cells, to promote TSLP-dependent allergic inflammatory responses, such as asthma and atopic dermatitis. The production of TSLP by DCs was not anticipated, because DCs have been viewed only as critical targets for this cytokine. DCs produce proinflammatory cytokines, including TNF-a, IL-1b, and IL-6 upon TLR ligation (27) . Therefore, we hypothesized that TSLP would also be produced by DCs resident in the gut, lung, and skin, organs that have proximity to the external environment upon TLR ligation by allergens/pathogens. In this regard, TLR pathways have been implicated in the pathogenesis of asthma (28, 30) , but a link between these pathways and the production of TSLP by DCs has not been reported. Our data that lung CD324 + CD11c + DCs induced TSLP mRNA upon HDM challenge suggested that production of TSLP by DCs could play a role in the development of asthma, with implications for other DC-dependent inflammatory diseases, as well.
In summary, TSLP was originally reported to be produced by epithelial cells and keratinocytes and to act on DCs, which, in turn, can activate T cells, thereby helping to bridge innate and adaptive immune response (8) . We previously showed that functional receptors for TSLP are also expressed on T cells and other lineages and that TSLPR + T cells are critical for OVA-induced lung inflammation (7) . Moreover, TSLP promotes T cell survival (4, 20) . Previously, it was shown that DCs respond to TSLP, but in this study, we showed that DCs also produce this cytokine. Thus, the production of TSLP by DCs may allow the direct activation of the adaptive immune response, complementing and possibly circumventing the requirement for epithelial cell/keratinocytederived TSLP in the activation of T cells and promoting T celldependent immune responses.
